Selected research
Market Structure
Global NTA-IDA Chelating Ligands Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global NTA-IDA Chelating Ligands market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for NTA-IDA Chelating Ligands is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for NTA-IDA Chelating Ligands is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for NTA-IDA Chelating Ligands is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for NTA-IDA Chelating Ligands is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of NTA-IDA Chelating Ligands include Merck, Bio-Rad, Bio-Works, Macherey-Nagel, Cube Biotech, G-Biosciences, GenScript, BestChrom and NanoMicro, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
On the production side, the report examines NTA-IDA Chelating Ligands output, growth rates, and market shares by manufacturer and by region (at regional and country level) for 2021-2026, with forecasts through 2032.
On the consumption side, the report analyzes sales of NTA-IDA Chelating Ligands by region (regional and country level), company, type, and application for 2021-2026 and provides forecasts through 2032.
The report provides an overview of the global NTA-IDA Chelating Ligands market in terms of capacity, output, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of NTA-IDA Chelating Ligands and consumption patterns in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents NTA-IDA Chelating Ligands sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by type and application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the NTA-IDA Chelating Ligands market size, projected growth trends, production technologies, key applications, and end-use industries.
NTA-IDA Chelating Ligands Segment by Company
Merck
Bio-Rad
Bio-Works
Macherey-Nagel
Cube Biotech
G-Biosciences
GenScript
BestChrom
NanoMicro
Duoning Biotech
Smart-Lifesciences
Resindion
Cytiva
Thermo Fisher Scientific
Qiagen
NTA-IDA Chelating Ligands Segment by Type
NTA Chelating Ligand
IDA Chelating Ligand
NTA and IDA Screening Set
Other IMAC Chelating Ligand
NTA-IDA Chelating Ligands Segment by Application
His-Tagged Protein Purification
Process Development and Scale-Up
Metal-Binding Protein Enrichment
Phosphopeptide Enrichment
Metal Ion Removal
Other Research Use
NTA-IDA Chelating Ligands Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global NTA-IDA Chelating Ligands market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of NTA-IDA Chelating Ligands and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of NTA-IDA Chelating Ligands.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the NTA-IDA Chelating Ligands market, including product definition, global market growth prospects, production value, capacity, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global NTA-IDA Chelating Ligands industry.
Chapter 3: Detailed analysis of NTA-IDA Chelating Ligands market competition landscape. Including NTA-IDA Chelating Ligands manufacturers' output value, output and average price from 2021 to 2026, as well as competition analysis indicators such as origin, product type, application, merger and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 7: Production/Production Value of NTA-IDA Chelating Ligands by region. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 8: Consumption of NTA-IDA Chelating Ligands in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- NTA Chelating Ligand
- IDA Chelating Ligand
- NTA and IDA Screening Set
- Other IMAC Chelating Ligand
Applications
- His-Tagged Protein Purification
- Process Development and Scale-Up
- Metal-Binding Protein Enrichment
- Phosphopeptide Enrichment
- Metal Ion Removal
- Other Research Use
Companies covered
- Merck
- Bio-Rad
- Bio-Works
- Macherey-Nagel
- Cube Biotech
- G-Biosciences
- GenScript
- BestChrom
- NanoMicro
- Duoning Biotech
- Smart-Lifesciences
- Resindion
- Cytiva
- Thermo Fisher Scientific
- Qiagen
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global NTA-IDA Chelating Ligands Production Value Estimates and Forecasts (2021-2032)
- 1.2.2 Global NTA-IDA Chelating Ligands Production Capacity Estimates and Forecasts (2021-2032)
- 1.2.3 Global NTA-IDA Chelating Ligands Production Estimates and Forecasts (2021-2032)
- 1.2.4 Global NTA-IDA Chelating Ligands Market Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Global NTA-IDA Chelating Ligands Market Dynamics
- 2.1 NTA-IDA Chelating Ligands Industry Trends
- 2.2 NTA-IDA Chelating Ligands Industry Drivers
- 2.3 NTA-IDA Chelating Ligands Industry Opportunities and Challenges
- 2.4 NTA-IDA Chelating Ligands Industry Restraints
3 NTA-IDA Chelating Ligands Market by Manufacturers
- 3.1 Global NTA-IDA Chelating Ligands Production Value by Manufacturers (2021-2026)
- 3.2 Global NTA-IDA Chelating Ligands Production by Manufacturers (2021-2026)
- 3.3 Global NTA-IDA Chelating Ligands Average Price by Manufacturers (2021-2026)
- 3.4 Global NTA-IDA Chelating Ligands Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global NTA-IDA Chelating Ligands Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global NTA-IDA Chelating Ligands Manufacturers, Product Type & Application
- 3.7 Global NTA-IDA Chelating Ligands Manufacturers Established Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global NTA-IDA Chelating Ligands Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 NTA-IDA Chelating Ligands Players Market Share by Production Value in 2025
- 3.8.3 2025 NTA-IDA Chelating Ligands Tier 1, Tier 2, and Tier 3
4 NTA-IDA Chelating Ligands Market by Type
- 4.1 NTA-IDA Chelating Ligands Type Introduction
- 4.1.1 NTA Chelating Ligand
- 4.1.2 IDA Chelating Ligand
- 4.1.3 NTA and IDA Screening Set
- 4.1.4 Other IMAC Chelating Ligand
- 4.2 Global NTA-IDA Chelating Ligands Production by Type
- 4.2.1 Global NTA-IDA Chelating Ligands Production by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global NTA-IDA Chelating Ligands Production by Type (2021-2032)
- 4.2.3 Global NTA-IDA Chelating Ligands Production Market Share by Type (2021-2032)
- 4.3 Global NTA-IDA Chelating Ligands Production Value by Type
- 4.3.1 Global NTA-IDA Chelating Ligands Production Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global NTA-IDA Chelating Ligands Production Value by Type (2021-2032)
- 4.3.3 Global NTA-IDA Chelating Ligands Production Value Market Share by Type (2021-2032)
5 NTA-IDA Chelating Ligands Market by Application
- 5.1 NTA-IDA Chelating Ligands Application Introduction
- 5.1.1 His-Tagged Protein Purification
- 5.1.2 Process Development and Scale-Up
- 5.1.3 Metal-Binding Protein Enrichment
- 5.1.4 Phosphopeptide Enrichment
- 5.1.5 Metal Ion Removal
- 5.1.6 Other Research Use
- 5.2 Global NTA-IDA Chelating Ligands Production by Application
- 5.2.1 Global NTA-IDA Chelating Ligands Production by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global NTA-IDA Chelating Ligands Production by Application (2021-2032)
- 5.2.3 Global NTA-IDA Chelating Ligands Production Market Share by Application (2021-2032)
- 5.3 Global NTA-IDA Chelating Ligands Production Value by Application
- 5.3.1 Global NTA-IDA Chelating Ligands Production Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global NTA-IDA Chelating Ligands Production Value by Application (2021-2032)
- 5.3.3 Global NTA-IDA Chelating Ligands Production Value Market Share by Application (2021-2032)
6 Company Profiles
- 6.1 Merck
- 6.1.1 Merck Company Information
- 6.1.2 Merck Business Overview
- 6.1.3 Merck NTA-IDA Chelating Ligands Production, Value and Gross Margin (2021-2026)
- 6.1.4 Merck NTA-IDA Chelating Ligands Product Portfolio
- 6.1.5 Merck Recent Developments
- 6.2 Bio-Rad
- 6.2.1 Bio-Rad Company Information
- 6.2.2 Bio-Rad Business Overview
- 6.2.3 Bio-Rad NTA-IDA Chelating Ligands Production, Value and Gross Margin (2021-2026)
- 6.2.4 Bio-Rad NTA-IDA Chelating Ligands Product Portfolio
- 6.2.5 Bio-Rad Recent Developments
- 6.3 Bio-Works
- 6.3.1 Bio-Works Company Information
- 6.3.2 Bio-Works Business Overview
- 6.3.3 Bio-Works NTA-IDA Chelating Ligands Production, Value and Gross Margin (2021-2026)
- 6.3.4 Bio-Works NTA-IDA Chelating Ligands Product Portfolio
- 6.3.5 Bio-Works Recent Developments
- 6.4 Macherey-Nagel
- 6.4.1 Macherey-Nagel Company Information
- 6.4.2 Macherey-Nagel Business Overview
- 6.4.3 Macherey-Nagel NTA-IDA Chelating Ligands Production, Value and Gross Margin (2021-2026)
- 6.4.4 Macherey-Nagel NTA-IDA Chelating Ligands Product Portfolio
- 6.4.5 Macherey-Nagel Recent Developments
- 6.5 Cube Biotech
- 6.5.1 Cube Biotech Company Information
- 6.5.2 Cube Biotech Business Overview
- 6.5.3 Cube Biotech NTA-IDA Chelating Ligands Production, Value and Gross Margin (2021-2026)
- 6.5.4 Cube Biotech NTA-IDA Chelating Ligands Product Portfolio
- 6.5.5 Cube Biotech Recent Developments
- 6.6 G-Biosciences
- 6.6.1 G-Biosciences Company Information
- 6.6.2 G-Biosciences Business Overview
- 6.6.3 G-Biosciences NTA-IDA Chelating Ligands Production, Value and Gross Margin (2021-2026)
- 6.6.4 G-Biosciences NTA-IDA Chelating Ligands Product Portfolio
- 6.6.5 G-Biosciences Recent Developments
- 6.7 GenScript
- 6.7.1 GenScript Company Information
- 6.7.2 GenScript Business Overview
- 6.7.3 GenScript NTA-IDA Chelating Ligands Production, Value and Gross Margin (2021-2026)
- 6.7.4 GenScript NTA-IDA Chelating Ligands Product Portfolio
- 6.7.5 GenScript Recent Developments
- 6.8 BestChrom
- 6.8.1 BestChrom Company Information
- 6.8.2 BestChrom Business Overview
- 6.8.3 BestChrom NTA-IDA Chelating Ligands Production, Value and Gross Margin (2021-2026)
- 6.8.4 BestChrom NTA-IDA Chelating Ligands Product Portfolio
- 6.8.5 BestChrom Recent Developments
- 6.9 NanoMicro
- 6.9.1 NanoMicro Company Information
- 6.9.2 NanoMicro Business Overview
- 6.9.3 NanoMicro NTA-IDA Chelating Ligands Production, Value and Gross Margin (2021-2026)
- 6.9.4 NanoMicro NTA-IDA Chelating Ligands Product Portfolio
- 6.9.5 NanoMicro Recent Developments
- 6.10 Duoning Biotech
- 6.10.1 Duoning Biotech Company Information
- 6.10.2 Duoning Biotech Business Overview
- 6.10.3 Duoning Biotech NTA-IDA Chelating Ligands Production, Value and Gross Margin (2021-2026)
- 6.10.4 Duoning Biotech NTA-IDA Chelating Ligands Product Portfolio
- 6.10.5 Duoning Biotech Recent Developments
- 6.11 Smart-Lifesciences
- 6.11.1 Smart-Lifesciences Company Information
- 6.11.2 Smart-Lifesciences Business Overview
- 6.11.3 Smart-Lifesciences NTA-IDA Chelating Ligands Production, Value and Gross Margin (2021-2026)
- 6.11.4 Smart-Lifesciences NTA-IDA Chelating Ligands Product Portfolio
- 6.11.5 Smart-Lifesciences Recent Developments
- 6.12 Resindion
- 6.12.1 Resindion Company Information
- 6.12.2 Resindion Business Overview
- 6.12.3 Resindion NTA-IDA Chelating Ligands Production, Value and Gross Margin (2021-2026)
- 6.12.4 Resindion NTA-IDA Chelating Ligands Product Portfolio
- 6.12.5 Resindion Recent Developments
- 6.13 Cytiva
- 6.13.1 Cytiva Company Information
- 6.13.2 Cytiva Business Overview
- 6.13.3 Cytiva NTA-IDA Chelating Ligands Production, Value and Gross Margin (2021-2026)
- 6.13.4 Cytiva NTA-IDA Chelating Ligands Product Portfolio
- 6.13.5 Cytiva Recent Developments
- 6.14 Thermo Fisher Scientific
- 6.14.1 Thermo Fisher Scientific Company Information
- 6.14.2 Thermo Fisher Scientific Business Overview
- 6.14.3 Thermo Fisher Scientific NTA-IDA Chelating Ligands Production, Value and Gross Margin (2021-2026)
- 6.14.4 Thermo Fisher Scientific NTA-IDA Chelating Ligands Product Portfolio
- 6.14.5 Thermo Fisher Scientific Recent Developments
- 6.15 Qiagen
- 6.15.1 Qiagen Company Information
- 6.15.2 Qiagen Business Overview
- 6.15.3 Qiagen NTA-IDA Chelating Ligands Production, Value and Gross Margin (2021-2026)
- 6.15.4 Qiagen NTA-IDA Chelating Ligands Product Portfolio
- 6.15.5 Qiagen Recent Developments
7 Global NTA-IDA Chelating Ligands Production by Region
- 7.1 Global NTA-IDA Chelating Ligands Production by Region: 2021 VS 2025 VS 2032
- 7.2 Global NTA-IDA Chelating Ligands Production by Region (2021-2032)
- 7.2.1 Global NTA-IDA Chelating Ligands Production by Region (2021-2026)
- 7.2.2 Global NTA-IDA Chelating Ligands Production Forecast by Region (2027-2032)
- 7.3 Global NTA-IDA Chelating Ligands Production by Region: 2021 VS 2025 VS 2032
- 7.4 Global NTA-IDA Chelating Ligands Production Value by Region (2021-2032)
- 7.4.1 Global NTA-IDA Chelating Ligands Production Value by Region (2021-2026)
- 7.4.2 Global NTA-IDA Chelating Ligands Production Value by Region (2027-2032)
- 7.5 Global NTA-IDA Chelating Ligands Market Price Analysis by Region (2021-2032)
- 7.6 Regional Production Value Trends (2021-2032)
- 7.6.1 North America NTA-IDA Chelating Ligands Production Value (2021-2032)
- 7.6.2 Europe NTA-IDA Chelating Ligands Production Value (2021-2032)
- 7.6.3 Asia-Pacific NTA-IDA Chelating Ligands Production Value (2021-2032)
- 7.6.4 South America NTA-IDA Chelating Ligands Production Value (2021-2032)
- 7.6.5 Middle East & Africa NTA-IDA Chelating Ligands Production Value (2021-2032)
8 Global NTA-IDA Chelating Ligands Consumption by Region
- 8.1 Global NTA-IDA Chelating Ligands Consumption by Region: 2021 VS 2025 VS 2032
- 8.2 Global NTA-IDA Chelating Ligands Consumption by Region (2021-2032)
- 8.2.1 Global NTA-IDA Chelating Ligands Consumption by Region (2021-2026)
- 8.2.2 Global NTA-IDA Chelating Ligands Consumption by Region (2027-2032)
- 8.3 North America
- 8.3.1 North America NTA-IDA Chelating Ligands Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3.2 North America NTA-IDA Chelating Ligands Consumption by Country (2021-2032)
- 8.3.3 U.S.
- 8.3.4 Canada
- 8.3.5 Mexico
- 8.4 Europe
- 8.4.1 Europe NTA-IDA Chelating Ligands Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.4.2 Europe NTA-IDA Chelating Ligands Consumption by Country (2021-2032)
- 8.4.3 Germany
- 8.4.4 France
- 8.4.5 U.K.
- 8.4.6 Italy
- 8.4.7 Netherlands
- 8.5 Asia Pacific
- 8.5.1 Asia Pacific NTA-IDA Chelating Ligands Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.5.2 Asia Pacific NTA-IDA Chelating Ligands Consumption by Country (2021-2032)
- 8.5.3 China
- 8.5.4 Japan
- 8.5.5 South Korea
- 8.5.6 Southeast Asia
- 8.5.7 India
- 8.5.8 Australia
- 8.6 South America
- 8.6.1 South America NTA-IDA Chelating Ligands Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.6.2 South America NTA-IDA Chelating Ligands Consumption by Country (2021-2032)
- 8.6.3 Brazil
- 8.6.4 Argentina
- 8.6.5 Chile
- 8.6.6 Colombia
- 8.7 Middle East & Africa
- 8.7.1 Middle East & Africa NTA-IDA Chelating Ligands Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.7.2 Middle East & Africa NTA-IDA Chelating Ligands Consumption by Country (2021-2032)
- 8.7.3 Egypt
- 8.7.4 South Africa
- 8.7.5 Israel
- 8.7.6 Türkiye
- 8.7.7 GCC Countries
9 Value Chain and Sales Channels Analysis
- 9.1 NTA-IDA Chelating Ligands Value Chain Analysis
- 9.1.1 NTA-IDA Chelating Ligands Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 NTA-IDA Chelating Ligands Production Mode & Process
- 9.2 NTA-IDA Chelating Ligands Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 NTA-IDA Chelating Ligands Distributors
- 9.2.3 NTA-IDA Chelating Ligands Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst